NEW YORK, NY—A novel, robotically-made polymer surgical valve has an “acceptable safety” profile and stable hemodynamics through 1 year of follow-up in younger patients with symptomatic mitral valve ...
SALT LAKE CITY--(BUSINESS WIRE)--Foldax®, Inc., a leader in the development of innovative, polymer heart valves, today announced that its TRIA valves have surpassed 200 patient life years in human ...
Hosted on MSN
Polymer Valve's Strong Debut in Mitral Valve Surgery
NEW YORK CITY -- Heart valve innovation has made polymer valves a reality, with one such device boasting good 1-year outcomes in a small single-arm study. Adults who received the Tria device for ...
NEW YORK, NY—A new mitral valve prosthesis—using a polymer designed to minimize the need for long-term anticoagulation—has demonstrated good hemodynamics at 30 days, with no signal of adverse clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results